Statement on the Biden-⁠Harris Plan to Revitalize American Manufacturing and Secure Critical Supply Chains in 2022

By Blair Childs, Senior Vice President, Public Affairs

While progress has been made in the past year to strengthen domestic manufacturing, Premier applauds the Administration’s recognition that a holistic multi-year strategy is needed to truly address key weaknesses in some of the nation’s most crucial supply chains. Diversifying the government’s approach to domestic manufacturing is essential. To sustain this progress and better insulate our nation from future supply chain disruptions, manufacturers need longer-term purchasing commitments and the recognition of the capital requirements needed to expand domestic manufacturing and maintain competitive prices. Congress should enact tax credits to achieve a truly competitive and sustainable domestic manufacturing base.

Premier has been a longstanding advocate for supply chain diversity and resiliency, helping 37 new generic manufacturers enter the market and fill gaps in production of critical drugs. We have also partnered with leading health systems to expand domestic and geographically diverse manufacturing capacity for masks, gloves, gowns, generic drugs and other crucial medical supplies. We look forward to continuing work in this area with the Administration, Congress, and our provider partners.